This work aims to measure the effectiveness of face mask worn by a patient with flu to avoid transmission to other persons in the household.
Background. Non pharmaceutical interventions, and in particular the wearing of face masks, could play a role in controlling the transmission of influenza in the early stages of the epidemic. In the French pandemic plan, surgical masks are recommended in contagious patients in wards. The effectiveness of such masks in preventing transmission of influenza A virus is unknown. Our project aims to assess the preventive efficacy and tolerance of surgical mask. The primary objective is to measure the decrease of the number of secondary cases of flu in households where the index case will wear a surgical mask during its period of infectiousness (5 days), compared to households where the index case will not be subject to this intervention. Secondary objectives are: (1) to study the feasibility and tolerance of wearing a mask continuously during the period of viral shedding; (2) virological description of infection spreading among household contacts based on virological collections.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
372
Non sterile surgical mask,high filtration "AEROKYN",type 2 with eardrop
Non sterile surgical mask, high filtration "AEROKYN", type 2 with eardrop Masks will be worn at home by the patient over a period of 5 days following inclusion, whenever a member of the household will attend the same room or in other confined space (eg car), and changed after 3 hours of consecutive use or sooner if they are tor Masks will not be worn: * during the night, * when the patient is alone in the room. Moreover, for all households, an incentive in nocturnal isolation of index-patient will be recommended
Hopital Saint Antoine
Paris, France
The number of household contacts who will develop within 7 days of the inclusion of the index patient a respiratory syndrome defined by fever> = 37.8 ° C and a cough or a sore throat.
Time frame: during the study
clinical events in all household members on the entire monitoring period (21 days).
Time frame: 21 days
Adverse events related to wearing a mask - a safety issue.
Time frame: during the study
Number of days of wearing a mask, number of masks used.
Time frame: during the study
Drug-consumption, in particular antibiotics
Time frame: during the study
Sick-leave from work (for adults contacts), or from school (for children of school age).
Time frame: during the study
Quality of life in the index patient.
Time frame: during the study
Infection with influenza virus at different time, among all household members.
Time frame: during the study
Quantification of viral load in patients infected.
Time frame: during the study
Characterization of viruses isolated (sub-type and sequence of the portion of HA1 gene for haemagglutinin).
Time frame: during the study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.